全文获取类型
收费全文 | 693篇 |
免费 | 43篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 10篇 |
妇产科学 | 35篇 |
基础医学 | 76篇 |
口腔科学 | 9篇 |
临床医学 | 52篇 |
内科学 | 173篇 |
皮肤病学 | 8篇 |
神经病学 | 75篇 |
特种医学 | 12篇 |
外科学 | 156篇 |
综合类 | 4篇 |
预防医学 | 30篇 |
眼科学 | 3篇 |
药学 | 53篇 |
肿瘤学 | 46篇 |
出版年
2023年 | 4篇 |
2022年 | 4篇 |
2021年 | 13篇 |
2020年 | 8篇 |
2019年 | 13篇 |
2018年 | 19篇 |
2017年 | 12篇 |
2016年 | 22篇 |
2015年 | 12篇 |
2014年 | 26篇 |
2013年 | 45篇 |
2012年 | 68篇 |
2011年 | 57篇 |
2010年 | 20篇 |
2009年 | 15篇 |
2008年 | 39篇 |
2007年 | 30篇 |
2006年 | 39篇 |
2005年 | 33篇 |
2004年 | 49篇 |
2003年 | 34篇 |
2002年 | 26篇 |
2001年 | 13篇 |
2000年 | 8篇 |
1999年 | 6篇 |
1998年 | 8篇 |
1997年 | 7篇 |
1996年 | 7篇 |
1995年 | 3篇 |
1994年 | 3篇 |
1993年 | 4篇 |
1992年 | 3篇 |
1991年 | 4篇 |
1990年 | 5篇 |
1989年 | 7篇 |
1988年 | 3篇 |
1987年 | 5篇 |
1986年 | 3篇 |
1985年 | 11篇 |
1984年 | 8篇 |
1982年 | 3篇 |
1980年 | 2篇 |
1978年 | 7篇 |
1977年 | 7篇 |
1975年 | 6篇 |
1974年 | 4篇 |
1973年 | 2篇 |
1972年 | 2篇 |
1968年 | 2篇 |
1966年 | 2篇 |
排序方式: 共有743条查询结果,搜索用时 31 毫秒
91.
Measles virus hemagglutination-inhibiting (HI) and gel precipitating (GP) antibodies were determined in sera and cerebrospinal fluids (CSF) from 65 patients with multiple sclerosis (MS) and 65 patients with other neurological diseases. The serological results were correlated to content of immunoglobulin-G (IgG) and electrophoretic patterns of sera and CSF.Measles GP antibodies, identified as directed against measles virus ribonucleoprotein antigens, were detected in sera and in CSF from a significantly higher proportion of MS than of non-MS patients. No significant difference between the 2 groups of patients was found for measles HI antibodies.Reduced serum/CSF HI and/or GP antibody ratios were found in about one half of the MS patients and in 2 patients with chronic myelopathy. All patients with reduced antibody ratios had evidence of IgG synthesis within the central nervous system (CNS), as inferred from oligoclonal IgG patterns of the CSF. Reduced ratios of measles GP antibodies were 3 times as common as reduced ratios of HI antibodies. Immuno-electrophoretic assays indicated that the CSF GP antibodies were electrophoretically restricted in a number of MS patients.The results indicate that measles virus may be an active immunogen within the CNS in many MS patients and in some patients with chronic myelopathy, giving rise to an oligoclonal IgG antibody response. 相似文献
92.
B la Szendes Lajos Kisfaludy K yoly Lapis L szl D nes Lajos zporny Olga Ny ke Istv n Schon Gy ygy Yaj s Julia Ember Miklos Constantin S ndor Paku C szlo J nossy 《Immunopharmacology and immunotoxicology》1985,7(1):67-78
The immunostimulatory action of oligopeptides RGH-0205 (Arg-Lys-Asp), RGH-0206 (Arg-Lys-Asp-Val) and TP-5 (4rg-Lys-Asp-Val-Tyr) was measured using the B10LP to C57BL skin graft system and the determination of splenic T cell ratio.
While thymectomy increased the period between skin grafting and rejection, each of the oligopeptides increased the number of spenic T cells and in same extent restored the rejection capacity of thymectomised C57B1 mice, presumably by restoration of thymic hormone function. 相似文献
While thymectomy increased the period between skin grafting and rejection, each of the oligopeptides increased the number of spenic T cells and in same extent restored the rejection capacity of thymectomised C57B1 mice, presumably by restoration of thymic hormone function. 相似文献
93.
The cholecystokinin (CCK) concentration in individual brain stem nuclei of rat was determined using the Palkovits punch method19 and the CCK RIA3. CCK has a unique distribution in the brain stem, unlike other neuropeptides and biogenic amines8,19. In general, the CCK levels in the brain stem are 5–20% of rat cerebral cortex. The colliculi, midbrain central gray, nucleus of the solitary tract, and the interpeduncular nucleus had the highest CCK content (2.7-1 ng CCK mg protein). 相似文献
94.
Smelson DA Ziedonis D Williams J Losonczy MF Williams J Steinberg ML Kaune M 《Journal of clinical psychopharmacology》2006,26(1):9-12
OBJECTIVE: Although a growing body of research suggests that atypical neuroleptic medications are efficacious in the treatment of cocaine addiction among individuals with schizophrenia, more rigorously controlled trials are needed. To extend this research, we performed a 6-week double-blind study comparing olanzapine to haloperidol with the primary objective of reducing cue-elicited cocaine craving and the secondary aims of decreasing substance use, improving psychiatric symptoms, and determining an effect size for future studies. METHODS: Thirty-one subjects with cocaine dependence and schizophrenia were randomized to olanzapine or haloperidol, underwent a cue-exposure procedure, and completed psychiatric and substance abuse ratings. RESULTS: Individuals in the olanzapine group who completed the study had a significant reduction on the energy subscale of the Voris Cocaine Craving Scale at study completion compared with individuals in the haloperidol group. The olanzapine-treated group also had lower, but not statistically significant, PANSS General Psychopathology Subscale scores and fewer positive urine toxicology screens compared with those in the haloperidol group. CONCLUSION: This small, but rigorously controlled, pilot trial provides additional evidence for the use of atypical antipsychotics for the treatment of individuals with co-occurring schizophrenia and cocaine dependence. Reductions in craving were associated with medium to large effect sizes. 相似文献
95.
Salzberg M Pless M Rochlitz C Ambrus K Scigalla P Herrmann R 《Investigational new drugs》2006,24(4):299-304
Summary Vascular endothelial growth factor (VEGF) is a potent stimulant of angiogenesis. SU5416, is a small molecule tyrosine kinase
inhibitor, and a potent inhibitor of VEGF- mediated Flk-1 receptor signaling. Intravenous agent SU5416 has shown evidence
of biological activity against a variety of tumor types. The current intravenous dosing regimen is not optimal for long-term
administration, which is needed for optimal efficacy. The aim of this study was to evaluate the safety profile and pharmacokinetics
of a Nanocrystal Colloidal DispersionTM (NCD) SU5416 formulation in humans. Patients with advanced and/or metastatic solid organ tumors were included in the trial;
various SU5416 regimens were tested for tolerability, safety and were evaluated concerning pharmacokinetics. The results of
this study indicate that induction of clearance after oral dosing of NCD SU5416 in humans occurs and is greater than following
IV administration. It has been confirmed that SU5416 is a high clearance compound, also as an oral NCD formulation. The NCD
formulation was well tolerated, but no effective drug serum levels could be achieved. These data help to understand the ADME
(Absorption, Distribution, Metabolism, Excretion) properties of indoline chemical class compounds. The lessons learned should
be applied in the development of next generation indoline anti-angiogenic and anti-tumor compounds. 相似文献
96.
The authors report on two blind ending bifid ureters and a blind ending double ureter. Two patients underwent surgery because of febrile condition and hypertension. The symptoms are not specific. The most constant complaint is colic-like pain attributable to retrograde peristalsis. In the establishment of the diagnosis intravenous urography is the most helpful. As the surgical solution, the blind ending ureter should be extirpated. 相似文献
97.
98.
99.
100.
Molnar MZ Kovesdy CP Mucsi I Bunnapradist S Streja E Krishnan M Kalantar-Zadeh K 《Kidney international》2011,80(2):218-224
To examine whether a higher body mass index (BMI) in kidney recipients is associated with delayed graft function (DGF), we analyzed data from 11,836 hemodialysis patients in the Scientific Registry of Transplant Recipients who underwent kidney transplantation. The patient cohort included women, blacks, and diabetics; the average age was 49 years; and the mean BMI was 26.8 kg/m(2). After adjusting for relevant covariates, multivariate logistic regression analyses found that one standard deviation increase in pretransplant BMI was associated with a higher risk of DGF (odds ratio (OR) 1.35). Compared with patients with a pretransplant BMI of 22-24.99 kg/m(2), overweight patients (BMI 25-29.99 kg/m(2)), mild obesity patients (BMI 30-34.99 kg/m(2)), and moderate-to-severe obesity patients (BMI 35 kg/m(2) and over) had a significantly higher risk of DGF, with ORs of 1.30, 1.42, and 2.18, respectively. Similar associations were found in all subgroups of patients. Hence, pretransplant overweight or obesity is associated with an incrementally higher risk of DGF. 相似文献